Citation

Eckstein M. J. Emerg. Med. 2008; 35(1): 59-65.

Affiliation

Department of Emergency Medicine, Keck School of Medicine of the University of Southern California, Division of Prehospital Care, Los Angeles County + University of Southern California Medical Center, and Los Angeles Fire Department, Los Angeles, Californ

Copyright

(Copyright © 2008, Elsevier Publishing)

DOI

10.1016/j.jemermed.2007.03.040

PMID

17976798

Abstract

The US government considers cyanide to be among the most likely agents of chemical terrorism. Cyanide differs from many other biological or chemical agents for which little or no defense is available because its individual and public health effects are largely remediable through appropriate preparedness and response. Because the toxicity of the cyanide antidote currently available in the United States renders it ill-suited for use in terrorist incidents and other situations requiring rapid out-of-hospital treatment, hydroxocobalamin-an effective and safe cyanide antidote being used in other countries-has been introduced in the United States. Unlike the other available cyanide antidote, hydroxocobalamin can be administered at the scene of a cyanide disaster, and it need not be reserved for cases of confirmed cyanide poisoning but can be administered in cases of suspected poisoning. Both of these attributes facilitate the rapid intervention necessary for saving lives. To realize the potential benefits of hydroxocobalamin, progress also needs to be realized in other aspects of readiness, including but not limited to developing plans for ensuring local and regional availability of antidote, educating emergency responders and health care professionals in the recognition and management of cyanide poisoning, and raising public awareness of the potential for a chemical weapons attack and of how to respond.

Language: en